Corcept Therapeutics

+$0.56 (+2.66%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol.

CEO

Joseph K. Belanoff

Employees

236

Headquarters

Menlo Park, California

Founded

1998

CORT Key Statistics

Market Cap

2.61B

Price-Earnings Ratio

27.04

Dividend Yield

—

Average Volume

654.63K

High Today

$21.65

Low Today

$20.87

Open Price

$21.01

Volume

674.10K

52 Week High

$31.18

52 Week Low

$12.20

CORT News

Simply Wall StJul 28

Corcept Therapeutics Incorporated's Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at Corcept Therapeutics' (NASDAQ:CORT) recent performance, when its stock has declined 16% over the past three months. H

CORT Earnings

$0.16

$0.22

$0.28

$0.34

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

$0.16 per share

Actual

$0.30 per share

Replay Earnings Call